Croatica Chemica Acta, Vol. 99 No. 3, 2026.
Original scientific paper
https://doi.org/10.5562/cca4375
Synthesis, Characterization and Biological Evaluation of Benzimidazole-Chalcones as Potent Anti-Breast Cancer Agents
Nagesh V. Edake
; Organic Chemistry Research Laboratory, School of Chemical Sciences, Punyashlok Ahilyadevi Holkar Solapur University, Solapur-413 255, Maharashtra, India
Dnyaneshwar M. Sirsat
; Department of Chemistry, Anandibai Raorane Arts, Commerce & Science College, Vaibhavwadi, Dist-Sindhudurg-416 810, Maharashtra, India
Samadhan A. Shenmare
; Department of Chemistry, Yeshwantrao Chavan Mahavidyalaya, Tuljapur, Dist-Dharashiv-413 601, Maharashtra, India
Sadanand N. Shringare
; Organic Chemistry Research Laboratory, School of Chemical Sciences, Punyashlok Ahilyadevi Holkar Solapur University, Solapur-413 255, Maharashtra, India
Nikita N. Mali
; Department of Chemistry, Sub-Campus, Dr. Babasaheb Ambedkar Marathwada University, Dharashiv-413 501, Maharashtra, India
Raghunath B. Bhosale
; Organic Chemistry Research Laboratory, School of Chemical Sciences, Punyashlok Ahilyadevi Holkar Solapur University, Solapur-413 255, Maharashtra, India
Pravin S. Bhale
; Department of Chemistry, Yeshwantrao Chavan Mahavidyalaya, Tuljapur, Dist-Dharashiv-413 601, Maharashtra, India
*
* Corresponding author.
Supplements: cca4375_supplement.pdf
Abstract
A novel series of benzimidazole–chalcone derivatives (6a–k) were synthesized and evaluated for their in vitro anticancer potential against human breast cancer cells and normal Vero cells. The target compounds were prepared via a base-catalyzed aldol condensation of
2-acetylbenzimidazole with various fluoro- and trifluoromethyl-substituted aromatic aldehydes under mild reaction conditions. The key inter¬mediate, 2-acetylbenzimidazole, was obtained through condensation of o-phenylenediamine or 4-methylbenzene-1,2-diamine with lactic acid followed by oxidation of the resulting hydroxyl intermediate. The anticancer activity of the synthesized benzimidazole–chalcones was assessed against the estrogen receptor–positive human breast cancer cell line MCF-7 using the sulforhodamine B (SRB) assay, while their cytotoxicity toward normal Vero cells was evaluated to assess preliminary selectivity. The compounds exhibited a broad spectrum of anticancer activity, with GI50 values ranging from low µM to inactive levels. Notably, fluoro-substituted derivatives displayed enhanced activity, with the difluoro analogue (E)-1-(1H-benzo[d]imidazol-2-yl)-3-(3,5-difluorophenyl)prop-2-en-1-one (6f) emerging as the most potent compound (GI50 = 3.66 µM), while derivatives bearing bulky trifluoromethyl substituents showed reduced or negligible activity. Against Vero cells, most derivatives displayed relatively weak growth inhibition, while selected compounds showed moderate activity. The comparatively higher GI50 values against Vero cells than MCF-7 cells for several derivatives suggest preliminary cancer-cell selectivity. Structure–activity relationship analysis revealed that both the nature and position of substituents significantly influence anticancer efficacy. Although less potent than adriamycin, several derivatives demonstrated promising cytostatic effects, highlighting the benzimidazole–chalcone scaffold as a valuable platform for further optimization and mechanistic exploration toward the development of improved anti-breast cancer agents.
Keywords
benzimidazole; chalcone; aldol condensation; anti-cancer activity
Hrčak ID:
353753
URI
Publication date:
11.11.2026.
Visits: 0 *